Your browser doesn't support javascript.
loading
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.
Iguchi, Taro; Tamada, Satoshi; Kato, Minoru; Yasuda, Sayaka; Machida, Yuichi; Ohmachi, Tetsuji; Ishii, Keiichi; Iwata, Hiroyuki; Yamamoto, Shinji; Kanamaru, Tomohiro; Morimoto, Kazuya; Hase, Taro; Tashiro, Koichiro; Harimoto, Koji; Deguchi, Takashi; Adachi, Takahisa; Iwamoto, Katsuki; Takegaki, Yoshinori; Nakatani, Tatsuya.
Afiliação
  • Iguchi T; Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. taro@msic.med.osaka-cu.ac.jp.
  • Tamada S; Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
  • Kato M; Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
  • Yasuda S; Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
  • Machida Y; Department of Urology, Yao Municipal Hospital, Yao, Japan.
  • Ohmachi T; Department of Urology, Bell-land General Hospital, Sakai, Japan.
  • Ishii K; Department of Urology, Osaka City General Hospital, Osaka, Japan.
  • Iwata H; Department of Urology, Itami City Hospital, Itami, Japan.
  • Yamamoto S; Department of Urology, Ikuwakai Memorial Hospital, Osaka, Japan.
  • Kanamaru T; Department of Urology, Yao Tokushukai General Hospital, Yao, Japan.
  • Morimoto K; Department of Urology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
  • Hase T; Department of Urology, Suita Municipal Hospital, Suita, Japan.
  • Tashiro K; Department of Urology, Meijibashi Hospital, Matsubara, Japan.
  • Harimoto K; Department of Urology, Fuchu Hospital, Izumi, Japan.
  • Deguchi T; Department of Urology, PL Hospital, Tondabayashi, Japan.
  • Adachi T; Department of Urology, Osaka City Juso Hospital, Osaka, Japan.
  • Iwamoto K; Department of Urology, Ishikiriseiki Hospital, Higashiosaka, Japan.
  • Takegaki Y; Department of Urology, Minamiosaka Hospital, Osaka, Japan.
  • Nakatani T; Department of Urology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Int J Clin Oncol ; 25(3): 486-494, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31564004

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Antagonistas de Androgênios Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Antagonistas de Androgênios Tipo de estudo: Clinical_trials Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article